advisorsecurities master

FBRXForte Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
15155
Ticker
FBRX
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-06-16
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
FBRX

Detail

Enriched 2026-08-14 20:47

Market cap
$1,573,221,662.54
Shares outstanding (class)
20,478,817
Shares outstanding (weighted)
20,489,993
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
22
Location
DALLAS, TX
Description

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data